论文信息 - Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapies - 字舞流文

Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapies

S. Corti | R. Finkel | C. Palermo | M. Pane | A. D’Amico | E. Bertini | S. Messina | A. Pini | M. Filosto | A. Varone | M. Piastra | Claudio Bruno | V. Sansone | A. Toscano | M. Donati | M. Pera | M. Pedemonte | M. Giannotta | A. Govoni | D. Leone | R. Cutrera | C. Ticci | E. Gitto | O. Genovese | R. Onesimo | R. Masson | G. Coratti | C. Dosi | M. Catteruccia | R. Zanin | E. Rolle | M. Sframeli | E. Albamonte | F. Salmin | R. de Sanctis | N. Forcina | M. Sacchini | N. Brolatti | Ilaria Bitetti | Michele Tosi | Chiara Bravetti | B. Berti | Delio Gagliardi | Rossella D’Alessandro | S. Morando | C. Agosto | Eugenio Mercuri | Irene Mizzoni | S. Carnicella | Giulia Stanca | M. Ricci | M. Chiarini | A. Capasso | Gaia Scarpini | F. Ricci | G. Cicala | Eleonora Salomon | Claudio Chierchi | Roberto Materia